Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Kalabus J"'
Autor:
Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Sarah Cannon Research Institute, Nashville, Tennessee., Chawla SP; Sarcoma Oncology Research Center, Santa Monica, California., Conley AP; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wilky BA; Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado., Tolcher A; NEXT Oncology, San Antonio, Texas., Lakhani NJ; START Midwest, Michigan., Berz D; Valkyrie Clinical Trials, Los Angeles, California., Andrianov V; Inhibrx, Inc, La Jolla, California., Crago W; Inhibrx, Inc, La Jolla, California., Holcomb M; Inhibrx, Inc, La Jolla, California., Hussain A; Inhibrx, Inc, La Jolla, California., Veldstra C; Inhibrx, Inc, La Jolla, California., Kalabus J; Inhibrx, Inc, La Jolla, California., O'Neill B; Inhibrx, Inc, La Jolla, California., Senne L; Inhibrx, Inc, La Jolla, California., Rowell E; Inhibrx, Inc, La Jolla, California., Heidt AB; Inhibrx, Inc, La Jolla, California., Willis KM; Inhibrx, Inc, La Jolla, California., Eckelman BP; Inhibrx, Inc, La Jolla, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 2988-3003.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Horibe K; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan. keizo.horibe@nnh.go.jp., Morris JD; Clinical Development, Amgen Inc., Thousand Oaks, CA, USA., Tuglus CA; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA., Dos Santos C; Clinical Biomarkers, Amgen Inc., South San Francisco, CA, USA., Kalabus J; Clinical Pharmacology, Amgen Inc., South San Francisco, CA, USA., Anderson A; Clinical Biomarkers, Amgen Inc., Thousand Oaks, CA, USA., Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan., Ogawa C; Department of Pediatric Oncology, National Cancer Center Hospital, Chūō, Tokyo, Japan.
Publikováno v:
International journal of hematology [Int J Hematol] 2020 Aug; Vol. 112 (2), pp. 223-233. Date of Electronic Publication: 2020 Jun 20.
Autor:
Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Morris JD; Amgen Inc., Thousand Oaks, California, USA., Oh I; Jichi Medical University, Tochigi-ken, Japan., Maeda Y; Okayama University Hospital, Okayama, Japan., Minami H; Medical Oncology/Hematology, Kobe University Graduate School of Medicine and Hospital, Kobe, Japan., Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan., Sakura T; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan., Iida H; National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Tuglus CA; Amgen Inc., Thousand Oaks, California, USA., Chen Y; Amgen Inc., Thousand Oaks, California, USA., Dos Santos C; Amgen Inc., South San Francisco, California, USA., Kalabus J; Amgen Inc., South San Francisco, California, USA., Anderson A; Amgen Inc., Thousand Oaks, California, USA., Hata T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan., Nakashima Y; Department of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan., Kobayashi Y; National Cancer Center Hospital, Tokyo, Japan.; International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
Publikováno v:
Cancer science [Cancer Sci] 2020 Apr; Vol. 111 (4), pp. 1314-1323. Date of Electronic Publication: 2020 Feb 11.
Autor:
Topp MS; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Duell J; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Zugmaier G; Amgen Research (Munich), Munich, Germany., Attal M; University of Toulouse, Toulouse, France., Moreau P; Hematology Department, University Hospital Center of Nantes, Nantes, France., Langer C; Kempten Clinic, Kempten, Germany., Krönke J; Ulm University, Ulm, Germany., Facon T; Regional University Hospital of Lille, Lille, France., Salnikov AV; Boehringer Ingelheim, Biberach, Germany., Lesley R; Amgen, South San Francisco, CA., Beutner K; Amgen, Thousand Oaks, CA., Kalabus J; Amgen, South San Francisco, CA., Rasmussen E; Amgen, Thousand Oaks, CA., Riemann K; Boehringer Ingelheim, Biberach, Germany., Minella AC; Amgen, Thousand Oaks, CA., Munzert G; Boehringer Ingelheim, Biberach, Germany., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Mar 10; Vol. 38 (8), pp. 775-783. Date of Electronic Publication: 2020 Jan 02.
Autor:
Cech, Paweł1 (AUTHOR) cech.pawel@gmail.com, Skórka, Katarzyna1 (AUTHOR) katarzyna.skorka7@gmail.com, Dziki, Laura1 (AUTHOR), Giannopoulos, Krzysztof1 (AUTHOR)
Publikováno v:
Cancers. Apr2024, Vol. 16 Issue 8, p1580. 27p.
Autor:
Brian W; Sanofi, Translational Medicine and Early Development, 55 Corporate Drive, Bridgewater, NJ 08807, USA., Tremaine LM; Pfizer Inc., Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA., Arefayene M; Biogen, Early Development Sciences, 14 Cambridge Center, Cambridge, MA 02142, USA., de Kanter R; Preclinical Pharmacokinetics and Metabolism, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland., Evers R; Merck & Co, Pharmacodynamics, Pharmacokinetics and Drug Metabolism, 2000 Galloping Hill Road, Kenilworth, NJ07033, USA., Guo Y; Eli Lilly and Company, Drug Disposition, LillyCorporate Center, Indianapolis, IN 46285, USA., Kalabus J; Novartis Pharmaceuticals, 1 Health Plaza, EastHanover, NJ 07936, USA., Lin W; Novartis Institutes for Biomedical Research, Drug Metabolism and Pharmacokinetics, One Health Plaza, East Hanover, NJ07936-1080, USA., Loi CM; Pfizer Inc., Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism,10646 Science Center Drive, San Diego, CA 92121, USA., Xiao G; Biogen, Preclinical PK and In vitro ADME, 14 Cambridge Center, Cambridge, MA 02142, USA.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2016 Apr; Vol. 17 (6), pp. 615-31. Date of Electronic Publication: 2016 Apr 05.